What is anticholinergic burden?
How medicines with anticholinergic effects can add up, what symptoms may prompt review, and what a burden scale can and cannot say.
Read article →Evidence-informed guides to medication effects, older-adult review, published ratings, and the research behind this tool.
How medicines with anticholinergic effects can add up, what symptoms may prompt review, and what a burden scale can and cannot say.
Read article →A plain-language guide to possible symptoms, what else could explain them, and how to bring concerns to a medication review.
Read article →The same ingredient can receive different categories because scales ask different questions and rely on different evidence.
Read article →How to interpret a 2023 AGS Beers anticholinergic flag without treating it as an automatic stop instruction or a burden score.
Read article →Why an over-the-counter label and duplicate ingredients matter, using diphenhydramine as a familiar example.
Read article →A practical checklist for discussing symptoms, benefits, doses, and over-the-counter products with a clinician or pharmacist.
Read article →A step-by-step guide to the match, published categories, older-adult flag, and unassigned 0–10 research score.
Read article →A look at ingredient matching, source rows, verification depth, and why a missing entry is not a published zero.
Read article →The project story: reconciling conflicting scales, documenting a model, reporting mixed validation, and opening the directory for corrections.
Read article →The experimental ratio and transformation explained without treating an index as a clinical risk probability.
Read article →Why reproducible calculations, outcome associations, dose and timing, and independent replication are different steps.
Read article →A qualified NHANES association, a null MEPS primary result, and why an unexecuted dose-aware protocol matters.
Read article →